Xcenda
We’ve moved! You can find information about our market access services at the Cencora | Pharma Solutions page.
We’ve moved! You can find information about our market access services at the Cencora | Pharma Solutions page.
Cencora (formerly AmerisourceBergen/Xcenda) is a leading global pharmaceutical solutions organization that aims to improve the lives of people and animals worldwide. The company, founded in 1994, focuses on facilitating and optimizing market access to therapies in the Health Care and Information Technology industries. With a workforce of over 46,000 individuals, Cencora is dedicated to creating healthier futures and is committed to delivering pharmaceuticals, healthcare products, and solutions. The company's annual revenue exceeds $200 billion, earning it a ranking of #11 on the Fortune 500 and #24 on the Global Fortune 500. Cencora's strategic consultancy services enable biopharma partners to effectively communicate and deliver their brand's value to global healthcare stakeholders, thereby driving market access globally. For further information, visit www.cencora.com.
There is no investment information
No recent news or press coverage available for Xcenda.
We care about your data, and we'd love to use cookies make your experience better.
